Infectious diseases specialist and clinical pharmacologist Kelly Dooley, MD, PhD, MPH, professor of Medicine, director of the Division of Infectious Diseases, and professor of Pathology, Microbiology and Immunology, has been named to the board of directors of the American Society for Clinical Pharmacology and Therapeutics (ASCPT). Her three-year term will begin this May.
Founded in 1900, ASCPT consists of more than 3,000 professionals seeking to advance the science and practice of clinical pharmacology and translational science for the benefit of patients and society. It counts itself the largest scientific and professional organization serving the disciplines of clinical pharmacology and translational science.
Dooley joined Vanderbilt University Medical Center in 2022 as director of the Division of Infectious Diseases. She studied economics at Northwestern University and, following a pre-med program at the University of Pennsylvania, received her medical degree from Duke University, her master’s in public health from the University of North Carolina at Chapel Hill, and her PhD in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. At Johns Hopkins she also completed an internal medicine residency, an infectious diseases fellowship and a clinical pharmacology fellowship.
